Dataset Information


Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells.

ABSTRACT: The state of phosphorylation of the retinoblastoma-susceptibility gene product, p110-115RB, is thought to have fundamental importance in controlling the progression of the cell through the cell cycle. We have studied RB phosphorylation in human T-cells in the context of T-cell activation, stimulated by phytohaemagglutinin (PHA) and interleukin-2 (IL-2). We show that, of the signals associated with T-cell activation, only signals that directly lead to movement into S phase of the cell cycle are capable of stimulating RB phosphorylation. Cyclosporin A (CsA), a potent inhibitor of IL-2 synthesis and cellular proliferation, blocked RB phosphorylation, and this was recovered with exogenous IL-2, indicating a direct involvement of IL-2 in controlling RB phosphorylation. We found that PHA did not stimulate RB phosphorylation within 10 h of treatment, but IL-2 could effectively stimulate RB phosphorylation within 2 h, and this approached a maximum within 8-10 h of IL-2 treatment. Further, by using actinomycin D to inhibit new gene transcription following IL-2 stimulation, we found that early-cell-cycle phosphorylation of RB required IL-2-stimulated gene transcription. From these data we conclude that, in human T-cells, RB phosphorylation is not directly associated with T-cell receptor-mediated events, but requires the interaction of IL-2 and new gene transcription following IL-2 stimulation.

PROVIDER: S-EPMC1130853 | BioStudies | 1992-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6029643 | BioStudies
1989-01-01 | S-EPMC1138390 | BioStudies
2007-01-01 | S-EPMC2013892 | BioStudies
| S-EPMC4851365 | BioStudies
| E-GEOD-56453 | BioStudies
| S-EPMC8124775 | BioStudies
| S-EPMC5085018 | BioStudies
| S-EPMC4076869 | BioStudies
| S-EPMC7564416 | BioStudies
| S-EPMC3709856 | BioStudies